rupintrivir rupintrivir rupintrivir (ag-7088, rupinavir) is a peptidomimetic antiviral drug which acts as a 3c and 3cl protease inhibitor. it was developed for the treatment of rhinoviruses, and has subsequently been investigated for the treatment of other viral diseases including those caused by picornaviruses, norovirus, and coronaviruses, such as sars and covid-19. rupintrivirclinical datatrade namesrupintrivirlegal statuslegal status us: investigational drug identifiers iupac name ethyl (e,4s)-4--6-methyl-5--4-oxoheptanoyl]amino]-5-pent-2-enoate cas number223537-30-2pubchem cid6440352drugbank05102chemspider4944627uniirge5k1q5qwkeggd05776chemblchembl20210chemical and physical dataformulac31h39fn4o7molar mass598.7 g·mol−13d model (jsmol)interactive image smiles ccoc(=o)/c=c/(c1ccnc1=o)nc(=o)(cc2=cc=c(c=c2)f)cc(=o)(c(c)c)nc(=o)c3=noc(=c3)c inchi inchi=1s/c31h39fn4o7/c1-5-42-27(38)11-10-24(16-21-12-13-33-29(21)39)34-30(40)22(15-20-6-8-23(32)9-7-20)17-26(37)28(18(2)3)35-31(41)25-14-19(4)43-36-25/h6-11,14,18,21-22,24,28h,5,12-13,15-17h2,1-4h3,(h,33,39)(h,34,40)(h,35,41)/b11-10+/t21-,22+,24+,28-/m0/s1key:cayjbrbgzbczko-bhgbqcossa-n